Single nucleotide polymorphisms in IL-1A RS1800587, IL-1B RS1143634 and vitamin D receptor rs731236 in stage III grade B/C periodontitis
Catégorie d'article: Original Article
Publié en ligne: 01 mars 2023
Pages: 51 - 60
DOI: https://doi.org/10.2478/bjmg-2022-0005
Mots clés
© 2022 Özturk Özener H., Tacal Aslan B., Eken B.F., Agrali Ö.B., Yildrim H.S., Altunok E.Ç., Ulucan K., Kuru L., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
As a chronic multifactorial infectious disease, periodontitis has been defined as one of the main public health problems with its high prevalence and it has been shown to lead to disability and tooth loss, impairment on aesthetic and chewing function, a presumed negative efect on general health, social inequality, and impaired quality of life [1]. It is described as microbially originated, host mediated inflammation resulting in periodontal attachment loss and, ultimately, tooth loss [2]. The etiopathogenetic mechanisms of periodontitis have not been completely discovered. Although the primary etiology of the disease is the pathogenic anaerobic bacteria found in the subgingival dental plaque; it has been shown that host susceptibility and the genetic background of individuals play substantial roles in the onset and development of the disease, in particular, with a subset of genes predominantly believed to be part of the pathological processes [3]. Researchers have completed studies on genetic association regarding the polymorphism analysis to further clarify the role of each of these genes. Polymorphisms may play a part in the presentation and/or outcome of diseases. This can also be done through conferring a degree of risk or protection from the disease.
Gene polymorphism, namely interleukin (IL)-1, is the most pronounced gene polymorphism studied in patients with periodontal diseases [4].
The vitamin D receptor (
Until now, the effects of the genetic factor on different forms of periodontal disease have been investigated in several studies, whereas the results obtained by different researchers vary. This study hypothesized that
The protocol of this cross-sectional study was approved by the Clinical Studies Ethical Committee of Faculty of Dentistry, Marmara University on 23.10.2017 with the reference number 2017-143, and registered at clinicaltrials. gov (identification number NCT04806971). According to the 2013 revision of the 1975 Helsinki Declaration, each participant signed an informed consent form prior to the study. All individuals provided a written informed consent. The present study recruited 200 individuals from the Department of Periodontology, Faculty of Dentistry, Marmara University between January 2018 and September 2019. The study population was made up of 100 periodontitis patients and 100 periodontally healthy subjects of Turkish origin.
Inclusion criteria for entry were as follows: previously untreated periodontitis patients, systemically healthy study population. Exclusion criteria included smoking (current and past); presence of systemic disease such as diabetes, rheumatic fever, kidney or liver diseases, neu-rologic deficiencies, immunologic diseases; pregnancy; received antibiotics within the last 6 months; use of any medication that may influence periodontium (chronic use of non-steroidal anti-inflammatory drugs, cyclosporine, nifedipine, phenytoin, etc.).
Periodontitis group: Stage III, Grade B/C periodontitis patients were diagnosed on the base of the new classification criteria [2,24]. Stage III periodontitis patients enrolled had ≥20 teeth, probing depth (PD) ≥6 mm, clinical attachment loss ≥5 mm, and bone loss reaching to the middle third of the root radiographically. Grade B was assessed by indirect consideration of radiographic bone loss throughout the most affected tooth in the dentition as a function of age (% bone loss/age: 0.25-1.0), and Grade C was evaluated based on the radiographic bone loss in the most affected tooth in whole dentition as a function of age (% bone loss/age: >1.0). Subjects in the periodontitis group were categorized into two subgroups, 51 patients Grade B and 49 patients Grade C.
Healthy group: The periodontally healthy subjects with the absence of any sign of clinical inflammation, not having periodontitis history; absence of detectable bone and/or attachment loss; <10% of sites with bleeding on probing (BOP); PD ≤3 mm; presence of 28 permanent teeth without extensive restorations or caries. In addition, all subjects in the healthy group did not show any local or systemic pathology.
Periodontal examinations were carried out by the same periodontist (HOO) using a periodontal probe (PCP 15 UNC, Hu-Friedy, Chicago, USA). Plaque index (PI) [25] and gingival index (GI) [26] were evaluated at 4 sites, PD, clinical attachment level (CAL) and BOP at 6 sites per tooth, excluding third molars. A calibration session was performed by using 10 subjects (not part of the study groups) to assess the intra-examiner reliability and full mouth PD and CAL scores were measured at two separate sessions, 24 hours apart. The intra-examiner correlation for PD and CAL measurements were calculated as 92.2% and 93% reproducibility, respectively.
4–6 ml venous blood samples were collected from the antecubital fossa of each individual and stored in ethylenediaminetetraacetic acid (EDTA) vacationer. DNA was extracted from the blood by using commercially available kits (Invitrogen, USA), following manufacturer’s guidelines. Sections of the
SPSS software version 25 was used for analyses. The descriptive statistics were presented using mean and standard deviation. Frequencies and percentages were used for categorical data. The Kolmogorov Smirnov test was performed to investigate to whether the variables are normally distributed or not. For association analysis between SNPs and periodontitis susceptibility, various genetic models were used by SNPassoc. The Mann-Whitney U test was done to compare the groups, since the variables were not normally distributed. Chi-Square test and Fisher’s exact test, where appropriate, was applied for comparison of the proportions of the groups. The study population obeys the rule of the Hardy-Weinberg equilibrium law, which was carried out with a goodness-of-fit χ2. Odds ratios with a 95% confidence interval were calculated for risk factors. A 5% type-I error level was used to interpret a statistical significance.
Table 1 demonstrates demographic data and clinical features of the periodontitis patients and the healthy subjects. All periodontal clinical parameters in the patients with periodontitis were significantly higher comparison to the healthy individuals, as expected (p<0.000).
Periodontal clinical parameters in study population
Parameters | Periodontitis N=100 Mean±SD | Healthy N=100 Mean±SD | P value |
---|---|---|---|
39.61 |
29.50±4.98 (21-55) | 0.000* | |
43 (43) |
38 (38) |
0.565† | |
2.88 |
1.79±0.33 | 0.000* | |
3.14 |
1.81±1.79 | 0.000* | |
1.70±0.45 | 0.34±0.20 | 0.000* | |
1.56±0.41 | 0.26±0.23 | 0.000* | |
58.82±21.91 | 8.77±6.25 | 0.000* |
*Mann Whitney U test, †Chi-Square, p<0.05.
PD: Probing Depth, CAL: Clinical Attachment Level, PI: Plaque Index, GI: Gingival Index, BOP: Bleeding on Probing.
In Table 2, the distributions of polymorphisms in all study populations agreed to the Hardy–Weinberg equilibrium (p > 0.05), except
Genotypic frequency of IL-1A, IL-1B and VDR polymorphisms in periodontitis and healthy population
Gene SNPs (rs number) | Genotype | Periodontitis N= 100 N (%) | Healthy N=100 N (%) | χ2 P value | OR (95% CI) | Fisher exact P value |
---|---|---|---|---|---|---|
49 (49) | 56 (56) | 0.793 | 1.142(0.420-3.107) | 0.804 | ||
42 (42) | 35 (35) | 0.727 | 0.833(2.327-2.327) | 0.796 | ||
9 (9) | 9 (9) | |||||
1.000 | 0.309 | |||||
60 (60) | 74 (74) | 0.371 | 1.726 (0.52-5.716) | 1.000 | ||
33 (33) | 21 (21) | 0.858 | 0.890 0.249-3.176) | 0.333 | ||
7 (7) | 5 (5) | |||||
0.867 | 0.005 | |||||
19 (19) | 10 (10) | 0.031 | 2.586(1,074-6.224) | 0.034 | ||
45 (45) | 41 (41) | 0.192 | 1.494 (0.817-2.732) | 0.222 | ||
36 (36) | 49 (49) | |||||
0.464 | 0.742 |
OR: odds ratio value, CI: confidence intervals, HWE: Hardy-Weinberg equilibrium, p<0.05.
The allelic distributions of each gene polymorphisms are presented in Table 3. Allele frequency regarding
Allelic frequency of IL-1A, IL-1B and VDR polymorphisms in periodontitis and healthy population
Gene SNPs (rs number) | Allele | Periodontitis N= 100 N (%) | Healthy N=100 N (%) | χ2 P value | OR (95% CI) | Fisher exact P value |
---|---|---|---|---|---|---|
C | 140 (70) | 147 (73.5) | 0.437 | 1.188 (0.768-1.838) | 0.505 | |
T | 60 (30) | 53 (26.5) | ||||
C | 153 (76.5) | 169 (84.5) | 0.045 | 1.167 (1.012-2.770) | 0.058 | |
T | 47 (23.5) | 31 (15.5) | ||||
C | 83 (41.5) | 61 (30.5) | 0.022 | 1.61 (1.071-2.441) | 0.029 | |
T | 117 (58.5) | 139 (69.5) |
OR: odds ratio value, CI: confidence intervals, p<0.05.
Model wise genotypic distributions regarding co-dominant, dominant, recessive and overdominant models are presented in Table 4. Model wise genotypic distribution of
Model wise genotypic distribution of IL-1A, IL-1B and VDR in periodontitis and healthy population
Genotypes and alleles | Periodontitis N (%) | Healthy N (%) | OR (95% CI) | χ2 P value |
---|---|---|---|---|
140 (70) | 147 (73.5) | 1.188 (0.768-1.838) | 0.437 | |
60 (30) | 53 (26.5) | |||
49 (49) | 56 (56) | 1.142 (0.420-3.107) | 0.793 | |
42 (42) | 35 (35) | 0.833 (2.327-2.327) | 0.727 | |
9 (9) | 9 (9) | |||
49 | 56 | |||
51 | 44 | 0.754 (0.432-1.316) | 0.322 | |
91 | 91 | |||
9 | 9 | 1.000 (0.380-2.634) | 1.000 | |
58 | 65 | |||
42 | 35 | 0.744 (0.420-1.317) | 0.309 | |
153 (76.5) | 169 (84.5) | 1.167 (1.012-2.770) | 0.045 | |
47 (23.5) | 31 (15.5) | |||
60 (60) | 74 (74) | 1.726 (0.52-5.716) | 0.371 | |
33 (33) | 21 (21) | 0.890 (0.249-3.176) | 0.858 | |
7 (7) | 5 (5) | |||
60 (60) | 74 (74) | |||
40 (40) | 26 (26) | 0.527 (0.289-0.960) | 0.035 | |
93 (93) | 95 (95) | |||
7 (7) | 5 (5) | 0.699 (0.214-2.282) | 0.522 | |
67 (67) | 79 (79) | 0.5397 (0,2855-1.021) | 0.058 | |
33 (33) | 21 (21) | |||
117 (58.5) | 139 (69.5) | 1.616 (1.07-2.44) | 0.022 | |
83 (41.5) | 61 (30.5) | |||
36 (36) | 49 (49) | 2.586 (1.074-6.224) | 0.034 | |
45 (45) | 41 (41) | 1.73 (0.721-4.152) | 0.218 | |
19 (19) | 10 (10) | |||
36 (36) | 49 (49) | |||
64 (64) | 51 (51) | 0.585 (0.332-1.031) | 0.063 | |
81 (81) | 90 (90) | |||
19 (19) | 10 (10) | 0.474 (0.208-1.078) | 0.075 | |
55 (55) | 59 (59) | |||
45 (45) | 41 (41) | 0.845 (0.485-1.487) | 0.568 |
OR: odds ratio value, CI: confidence intervals, p<0.05.
Associations between different grades of periodontitis and gene polymorphisms in
Recent evidence has shown that, with the continuous advancement of genetic engineering technology, gene polymorphism can be an important basis for the individual diferences in the development and progression of periodontitis. In this study, the frequencies of
SNPs from the promoter region, which play an essential role the transcriptional regulation in the coding region, can afect the expression of a gene. The genes in IL-1 family possess allele polymorphisms in which SNP -889C/T (rs1800587) in
The
Genetic factors are of great importance in identifying the host’s immune response to infection and could account for significant variation in the severity, distribution, and extension of the disease [47, 48, 49]. The grade of periodontitis is predicted by direct or indirect evidence of the progression rate of in three levels: Grade A (slow progression), Grade B (moderate progression) and Grade C (rapid progression) [2]. With the given facts, the present study investigated whether SNPs rs1800587, rs1143634 and rs731236 might be related with the progression of periodontal disease in a group of the Turkish population. In our study, healthy individuals and Grade B and Grade C Stage III periodontitis patients were evaluated and compared. T allele of the rs1143634 was linked to patients having Grade B Stage III periodontitis. Our finding was in accordance with da Silva et al. [14], who revealed that T allele of the rs1143634 was related with an increased risk of periodontal disease in Asians, Caucasians and in a mixed population. The outcome of the present study demonstrated that rs731236 (
Genotypic and allelic frequency of IL-1A, IL-1B and VDR polymorphisms in Grade B and
Gene SNPs (rs number) | Genotypes and Alleles | Grade B Periodontitis N=51 | Grade C Periodontitis N=49 | Healthy N= 100 N (%) | Grade B Periodontitis |
Grade C Periodontitis |
Grade B Periodontitis VS Grade C Periodontitis | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N (%) | N (%) | χ2 (p value) | OR (95% CI) | Fisher exact (p value) | χ2 (p value) | OR (95% CI) | Fisher exact (p value) | χ2 (p value) | OR (95% CI) | Fisher exact (p value) | ||||
26(51) | 23 (46.9) | 56 (56) | 0.608 | 0.718(0.179-2.874) 0.539(0.129-2.175) | 0.749 | 0.403 | 1.623 (0.518-5.082) 1.167(0.362-3.756) | 0.543 | 0.277 | 2.261 (0.507-10.07) 2.200(0.485-9.983) | 0.470 | |||
22(43.1) | 20(40.8) | 35 (35) | 0.323 | 0.515 | 0.796 | 1.000 | 0.300 | 0.485 | ||||||
3(5.9) | 6(12.2) | 9(9) | ||||||||||||
74(72.5) | 66(67.3) | 147(73.5) | 0.806 | 1.07(0.625-1.831) | 0.890 | 0.241 | 1.372(0.809-2.323) | 0.273 | 0.422 | 1.281 (0.699-2.349) | 0.444 | |||
28 (27.5) | 32(32,7) | 53 (26.5) | ||||||||||||
29(56.9) | 31(63.3) | 74(74) | 0.304 | 0.490(0.123-1.953) 1.071 (0.249-4.603) | 0.445 | 0.635 | 0.698(0.157-3.103) 1.190(0.246-5.794) | 0.695 | 0.659 | 0.702(0.144-3.407) 0.900(0.173-4.669) | 0.709 | |||
18(35.3) | 15(30.6) | 21(21) | 0.926 | 1.000 | 0.828 | 1.000 | 0.900 | 1.000 | ||||||
4(7.8) | 3(6.1) | 5(5) | ||||||||||||
76(74.5) | 77(78.6) | 169(84.5) | 0.036 | 1.865 (1.037-3.355) | 0.043 | 0.205 | 0.673(0.363-1.245) | 0.255 | 0.498 | 0.797(0.413-1.537) | 0.510 | |||
26 (25.5) | 21(21.4) | 31(15.5) | ||||||||||||
9(17.6) | 10(20.4) | 10(10) | 0.024 | 3.392(1.142- 10.075) | 0.038 | 0.136 | 3.769(1.295-10.975) 0.831 (0.388-1.780) | 0.188 | 0.564 | 1.592(0,515-4,922) 3.207(1.286-7.997) | 0.300 | |||
29(56.9) | 16(32.7) | 41(41) | 0.012 | 2.666(1.229-5.785) | 0.015 | 0.634 | 0.702 | 0.011 | 0.014 | |||||
13(25.5) | 23 (46.9) | 49(49) | ||||||||||||
47(46.1) | 36(36.7) | 61(30.5) | 0.008 | 1.947(1.190-3.185) | 0.011 | 0.281 | 1.323 (0.795-2.202) | 0.295 | 0.180 | 1.472(0.836-2.592) | 0.198 | |||
55 (53.9) | 62(63.3) | 139 (69.5) |
OR: odds ratio value, CI: confidence intervals, p<0.05
In conclusion, CC genotype and C allele of